Decision making and quality of life in the treatment of cancer: a review
暂无分享,去创建一个
Amy P. Abernethy | Kevin P. Weinfurt | Kevin A. Schulman | Stewart C. Alexander | A. Abernethy | K. Weinfurt | K. Schulman | S. Alexander | S. Y. Zafar | S. Yousuf Zafar | Kevin A. Schulman | S. Yousuf Zafar | Stewart C. Alexander | Kevin P. Weinfurt | Amy P. Abernethy | S. Zafar
[1] P. Butow,et al. A matter of trust – patient's views on decision‐making in colorectal cancer , 2004, Health expectations : an international journal of public participation in health care and health policy.
[2] F. Wright,et al. Impact of lymph node retrieval and pathological ultra‐staging on the prognosis of stage II colon cancer , 2003, Journal of surgical oncology.
[3] W. Mackillop,et al. Cancer patients' perceptions of their disease and its treatment. , 1988, British Journal of Cancer.
[4] C. Begg,et al. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] E. Bruera,et al. Patient preferences versus physician perceptions of treatment decisions in cancer care. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] M. Tinetti,et al. Multimorbidity and Survival in Older Persons with Colorectal Cancer , 2006, Journal of the American Geriatrics Society.
[7] D. West,et al. Differences in treatment patterns for localized breast carcinoma among Asian/Pacific islander women , 2002, Cancer.
[8] M. Sprangers,et al. An introduction to quality of life assessment in oncology: the value of measuring patient-reported outcomes. , 2002, The American journal of managed care.
[9] K C Carriere,et al. Information needs and decisional preferences in women with breast cancer. , 1997, JAMA.
[10] A. Stiggelbout,et al. Choices in oncology: factors that influence patients' treatment preference , 1994, Quality of Life Research.
[11] A. Dueck,et al. Integrating QOL assessments for clinical and research purposes. , 2006, Current problems in cancer.
[12] I. Kai,et al. Japanese cancer patient participation in and satisfaction with treatment-related decision-making: A qualitative study , 2008, BMC public health.
[13] M. Grossman. On the Concept of Health Capital and the Demand for Health , 1972, Journal of Political Economy.
[14] D. August,et al. Racial differences in the treatment of colorectal cancer: a comparison of surgical and radiation therapy between Whites and Blacks. , 2004, Annals of epidemiology.
[15] L. Ellis,et al. How well do we communicate with patients concerning adjuvant systemic therapy? A survey of 150 colorectal cancer survivors , 2007 .
[16] Xianglin L. Du,et al. Racial disparities and socioeconomic status in association with survival in a large population‐based cohort of elderly patients with colon cancer , 2007, Cancer.
[17] J. Davis,et al. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. , 2000, Archives of surgery.
[18] R. Simes,et al. Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed? , 2001, Journal of the National Cancer Institute. Monographs.
[19] G. Pond,et al. Analysis of treatment practices for elderly cancer patients in Ontario, Canada. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] K. Schulman,et al. Treatment choices by seriously ill patients: the Health Stock Risk Adjustment model. , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[21] J. Guillem,et al. Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients. , 1997, Journal of the American College of Surgeons.
[22] A. Norman,et al. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Ree Dawson,et al. Dynamic treatment regimes: practical design considerations , 2004, Clinical trials.
[24] E. Cook,et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. , 1998, JAMA.
[25] C. Tournigand,et al. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] M. Šimunović,et al. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: A population‐based study , 2006, Journal of surgical oncology.
[27] D. Cella,et al. Someone to live for: social well-being, parenthood status, and decision-making in oncology. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] W. Barlow,et al. Explaining black-white differences in receipt of recommended colon cancer treatment. , 2005, Journal of the National Cancer Institute.
[29] U. Ohman. Prognosis in patients with obstructing colorectal carcinoma. , 1982, American journal of surgery.
[30] M. Atkins,et al. Patient preferences for adjuvant interferon alfa-2b treatment. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] S. Jansen,et al. Unstable Preferences: , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.
[32] C. Davis,et al. Surgery for colorectal cancer in elderly patients: a systematic review , 2000, The Lancet.
[33] S. Murphy,et al. Developing adaptive treatment strategies in substance abuse research. , 2007, Drug and alcohol dependence.
[34] J. Wong,et al. Impact of the Number of Negative Nodes on Disease-Free Survival in Colorectal Cancer Patients , 2002, Diseases of the colon and rectum.
[35] W. Scheithauer,et al. Impact on quality of life of adding cetuximab to irinotecan in patients who have failed prior oxaliplatin-based therapy: The EPIC trial , 2007 .
[36] K. Schulman,et al. Impact of quality of life on patient expectations regarding phase I clinical trials. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] K. Weinfurt,et al. An Exploration of Relative Health Stock in Advanced Cancer Patients , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.
[38] C K Daugherty,et al. Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients. , 2000, IRB.
[39] C. Begg,et al. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. , 2001, Journal of the National Cancer Institute.
[40] A. Zaslavsky,et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] E. Bradley,et al. What matters to seriously ill older persons making end-of-life treatment decisions?: A qualitative study. , 2003, Journal of palliative medicine.
[42] P. Butow,et al. What Do Patients Want? , 2003, Diseases of the colon and rectum.
[43] K. Ang,et al. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] Barbara Leake,et al. Racial/ethnic group differences in treatment decision‐making and treatment received among older breast carcinoma patients , 2006, Cancer.
[45] N F Boyd,et al. Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences. , 1987, Journal of chronic diseases.
[46] C. Tangen,et al. Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report , 1995, Annals of Internal Medicine.
[47] Ree Dawson,et al. Flexible treatment strategies in chronic disease: clinical and research implications , 2000, Biological Psychiatry.
[48] D. Berger,et al. Outcomes of Veterans Affairs patients older than age 80 after surgical procedures for colon malignancies. , 2007, American journal of surgery.
[49] W. Otten,et al. How important is the opinion of significant others to cancer patients’ adjuvant chemotherapy decision-making? , 2007, Supportive Care in Cancer.
[50] G. Witham,et al. Exploring the decision‐making preferences of people with colorectal cancer , 2005, Health expectations : an international journal of public participation in health care and health policy.
[51] D. Murphy,et al. The support study , 1990 .
[52] J. Meyerhardt,et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] Deborah Schrag,et al. Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] P. Butow,et al. Sharing decisions in cancer care. , 2001, Social science & medicine.
[55] M. Tinetti,et al. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer , 2007, Cancer.
[56] A. Naeim,et al. Perspectives, preferences, care practices, and outcomes in late-stage cancer patients: connecting the dots. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[57] K. Weinfurt,et al. The correlation between patient characteristics and expectations of benefit from Phase I clinical trials , 2003, Cancer.
[58] C. Lynch,et al. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[59] B. Cassileth,et al. Information and participation preferences among cancer patients. , 1980, Annals of internal medicine.
[60] Neal J Meropol,et al. Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[61] W. Otten,et al. Review of determinants of patients' preferences for adjuvant therapy in cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[62] The SUPPORT study. Introduction. , 1990, Journal of clinical epidemiology.
[63] D. Tu,et al. Quality of life in patients with advanced colorectal cancer treated with cetuximab: Results of the NCIC CTG and AGITG CO.17 trial , 2007 .
[64] L. Braitman,et al. Treatment preferences and advance care planning at end of life: The role of ethnicity and spiritual coping in cancer patients , 2005, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.